These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29215317)

  • 21. Implanted Tissue-Engineered Vascular Graft Cell Isolation with Single-Cell RNA Sequencing Analysis.
    Mirhaidari GJM; Barker JC; Breuer CK; Reinhardt JW
    Tissue Eng Part C Methods; 2023 Feb; 29(2):72-84. PubMed ID: 36719780
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Keshavarzian M; Meyer CA; Hayenga HN
    Tissue Eng Part C Methods; 2019 Nov; 25(11):641-654. PubMed ID: 31392930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous Orthogonal Alignment of Smooth Muscle Cells and Endothelial Cells Captures Native Blood Vessel Morphology in Tissue-Engineered Vascular Grafts.
    Alkazemi H; Huang T; Mail M; Lokmic-Tomkins Z; Heath DE; O'Connor AJ
    ACS Appl Mater Interfaces; 2023 Jul; 15(29):34631-34641. PubMed ID: 37440289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Current Status of Tissue-Engineered Vascular Grafts.
    Jaspan VN; Hines GL
    Cardiol Rev; 2015; 23(5):236-9. PubMed ID: 25699981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.
    Roh JD; Sawh-Martinez R; Brennan MP; Jay SM; Devine L; Rao DA; Yi T; Mirensky TL; Nalbandian A; Udelsman B; Hibino N; Shinoka T; Saltzman WM; Snyder E; Kyriakides TR; Pober JS; Breuer CK
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4669-74. PubMed ID: 20207947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings.
    Nelson GN; Mirensky T; Brennan MP; Roh JD; Yi T; Wang Y; Breuer CK
    Arch Surg; 2008 May; 143(5):488-94. PubMed ID: 18490559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review: Tissue Engineering of Small-Diameter Vascular Grafts and Their In Vivo Evaluation in Large Animals and Humans.
    Fang S; Ellman DG; Andersen DC
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression.
    Fukunishi T; Ong CS; He YJ; Inoue T; Zhang H; Steppan J; Matsushita H; Johnson J; Santhanam L; Hibino N
    Tissue Eng Part A; 2021 Nov; 27(21-22):1368-1375. PubMed ID: 33599167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrospun scaffolds for tissue engineering of vascular grafts.
    Hasan A; Memic A; Annabi N; Hossain M; Paul A; Dokmeci MR; Dehghani F; Khademhosseini A
    Acta Biomater; 2014 Jan; 10(1):11-25. PubMed ID: 23973391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases.
    Cummings I; George S; Kelm J; Schmidt D; Emmert MY; Weber B; Zünd G; Hoerstrup SP
    Eur J Cardiothorac Surg; 2012 Jan; 41(1):167-72. PubMed ID: 21530291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.
    Fukunishi T; Best CA; Ong CS; Groehl T; Reinhardt J; Yi T; Miyachi H; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N
    Tissue Eng Part A; 2018 Jan; 24(1-2):135-144. PubMed ID: 28486019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges and Strategies for Endothelializing Decellularized Small-Diameter Tissue-Engineered Vessel Grafts.
    Ding H; Hou X; Gao Z; Guo Y; Liao B; Wan J
    Adv Healthc Mater; 2024 Jun; 13(16):e2304432. PubMed ID: 38462702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meso-Rex bypass for the management of extrahepatic portal vein obstruction in adults (with video).
    Brichard M; Iesari S; Lerut J; Reding R; Goffette P; Coubeau L
    Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):25-32. PubMed ID: 34426078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biofabrication of small diameter tissue-engineered vascular grafts.
    Weekes A; Bartnikowski N; Pinto N; Jenkins J; Meinert C; Klein TJ
    Acta Biomater; 2022 Jan; 138():92-111. PubMed ID: 34781026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Self-Assembly of Bioengineered Cardiovascular Bypass Grafts From Scaffold-Stabilized, Tubular Bilevel Cell Sheets.
    von Bornstädt D; Wang H; Paulsen MJ; Goldstone AB; Eskandari A; Thakore A; Stapleton L; Steele AN; Truong VN; Jaatinen K; Hironaka C; Woo YJ
    Circulation; 2018 Nov; 138(19):2130-2144. PubMed ID: 30474423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular grafts.
    Kurobe H; Maxfield MW; Naito Y; Cleary M; Stacy MR; Solomon D; Rocco KA; Tara S; Lee AY; Sinusas AJ; Snyder EL; Shinoka T; Breuer CK
    Tissue Eng Part C Methods; 2015 Jan; 21(1):88-93. PubMed ID: 24866863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Portal-to-right portal vein bypass for extrahepatic portal vein obstruction.
    Long L; Jinshan Z; Zhen C; Qi L; Ning D; Mei D; Wei C
    J Pediatr Surg; 2018 Jul; 53(7):1403-1407. PubMed ID: 29198895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative enlargement and prognostic effects of portal venous bypass grafts in children undergoing Rex shunt.
    Zhang JS; Li L; Cheng W
    J Vasc Surg Venous Lymphat Disord; 2018 Nov; 6(6):742-747. PubMed ID: 29802064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo.
    Nelson GN; Roh JD; Mirensky TL; Wang Y; Yi T; Tellides G; Pober JS; Shkarin P; Shapiro EM; Saltzman WM; Papademetris X; Fahmy TM; Breuer CK
    FASEB J; 2008 Nov; 22(11):3888-95. PubMed ID: 18711027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo Functional Evaluation of Tissue-Engineered Vascular Grafts Fabricated Using Human Adipose-Derived Stem Cells from High Cardiovascular Risk Populations.
    Krawiec JT; Weinbaum JS; Liao HT; Ramaswamy AK; Pezzone DJ; Josowitz AD; D'Amore A; Rubin JP; Wagner WR; Vorp DA
    Tissue Eng Part A; 2016 May; 22(9-10):765-75. PubMed ID: 27079751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.